No difference in quality of life (QoL) among people who switched from injectable to oral disease modifying treatment (DMT) compared to those who stayed on injectable in a community cohort: a propensity score matched (PSM) analysis

Authors

• tamela stuchiner, Providence Brain and Spine InstituteFollow
• Lindsay Lucas, Providence Brain and Spine InstituteFollow
• Elizabeth Baraban, Providence Brain and Spine InstituteFollow
• Chiayi Chen, Providence Brain and Spine InstituteFollow
• Stanley Cohan, Providence Brain and Spine Institute; Providence Multiple Sclerosis Center, Portland, OR, USAFollow

Document Type

Presentation

Publication Date

2019

Keywords

oregon; providence neuroscience institute

Area of Special Interest

Neurosciences (Brain & Spine)

Specialty/Research Institute

Neurosciences